Latest stories on SCTX
Scribe Therapeutics Updates Governance Following Initial Public Offering
TipRanks50 · neutralgeneral
Scribe Therapeutics, Inc. (SCTX) files 8-K
SEC 8-K50 · neutralgeneral
Scribe's Genetic Editing Aims to Prevent Heart Attacks
Barron's73 · bullishproduct/pr
Scribe Therapeutics raises $155.51M in IPO on Nasdaq
Investing.com Markets24 · bearishgeneral
Why is Scribe Therapeutics stock surging today?
Investing.com Markets50 · neutralgeneral
Eli Lilly and Sanofi-backed Scribe surges in public debut
Seeking Alpha76 · bullishearnings
Eli Lilly-Backed Scribe Therapeutics Soars 50% After IPO
Bloomberg73 · bullishgeneral
SCTX Barchart Opinion for Scribe Therapeutics Stock
Barchart50 · neutralanalyst
Scribe Therapeutics prices upsized IPO at $15/share
Seeking Alpha24 · bearishgeneral
Eli Lilly-backed Scribe Therapeutics raises $128.7M in upsized IPO; set to trade on Nasdaq
Seeking Alpha42 · neutralgeneral
Eli Lilly-Backed Scribe Raises $128.7 Million in Upsized IPO
Bloomberg63 · neutralgeneral
Scribe Therapeutics prices IPO at $15 per share on Nasdaq
Investing.com Markets53 · neutralgeneral
Scribe Therapeutics Announces Pricing of Upsized Initial Public Offering | SCTX Stock News
StockTitan24 · bearishgeneral
Scribe secures $129M in a rare gene editing IPO
Yahoo Top58 · neutralgeneral
Scribe Therapeutics IPO expected to price at top of range - Bloomberg
Investing.com Markets65 · bullishgeneral
Nabla names new CEO as AI scribe looks to scale
Yahoo Top56 · neutralgeneral
Scribe Therapeutics Starts IPO Effort For CRISPR Pipeline Development
Seeking Alpha56 · neutralgeneral
Scribe Therapeutics to Sell 7.15 Million Shares at $13-$15 Each in IPO
Morningstar24 · bearishgeneral
Eli Lilly-Backed Scribe Therapeutics Seeks $107.2 Million in IPO
Bloomberg56 · neutralgeneral